| Schedule of Segment Reporting Information, by Segment |
|
|
|
Year ended
|
| |
|
December 31, 2020
|
|
December 31, 2019
|
|
Segment Net Sales:
|
|
|
|
|
|
|
|
|
|
Cannabinoid
|
|
$
|
2,511 |
|
|
$
|
133 |
|
|
Non-Cannabinoid
|
|
|
9,606 |
|
|
|
7,701 |
|
|
Total Net Sales
|
|
|
12,117 |
|
|
|
7,834 |
|
| |
|
|
|
|
|
|
|
|
|
Segment Profit (Loss):
|
|
|
|
|
|
|
|
|
|
Cannabinoid
|
|
|
(18,798 |
)
|
|
|
(25,250 |
)
|
|
Non-Cannabinoid
|
|
|
1,863 |
|
|
|
614 |
|
|
Total Loss
|
|
$
|
(16,935 |
)
|
|
$
|
(24,636 |
)
|
| |
|
|
|
|
|
|
|
|
|
Reconciliation:
|
|
|
|
|
|
|
|
|
|
Total Segment Loss
|
|
|
(16,935 |
)
|
|
|
(24,636 |
)
|
|
Unallocated corporate expenses
|
|
|
(6,405 |
)
|
|
|
(5,887 |
)
|
|
Non-cash share based compensation
|
|
|
(1,652 |
)
|
|
|
(1,522 |
)
|
|
Depreciation and amortization
|
|
|
(1,854 |
)
|
|
|
(1,480 |
)
|
|
Herbal Brands acquisition related charges
|
|
|
|
|
|
|
(3,015 |
)
|
|
Goodwill impairment
|
|
|
(1,682 |
)
|
|
|
|
|
|
Loss from operations
|
|
$
|
(28,528 |
)
|
|
$
|
(36,540 |
)
|
| |
|
|
|
|
|
|
|
|
|
Loss on debt extinguishment
|
|
|
2,360 |
|
|
|
3,374 |
|
|
Loss on fair value of derivative instrument
|
|
|
657 |
|
|
|
421 |
|
|
Loss on investments
|
|
|
464 |
|
|
|
756 |
|
|
Foreign exchange loss
|
|
|
491 |
|
|
|
1,575 |
|
|
Interest expense
|
|
|
4,455 |
|
|
|
2,684 |
|
|
Miscellaneous, net
|
|
|
(284 |
)
|
|
|
534 |
|
|
Loss from operations before income taxes
|
|
$
|
(36,671 |
)
|
|
$
|
(45,884 |
)
|
|
|
|
December 31, 2020
|
|
December 31, 2019
|
|
Long-lived assets
|
|
|
|
|
|
|
|
Cannabinoid
|
|
$
|
25,485 |
|
$
|
24,209 |
|
Non-Cannabinoid
|
|
|
176 |
|
|
207 |
|
Other(a)
|
|
|
19 |
|
|
16 |
| |
|
$
|
25,680 |
|
$
|
24,432 |
|
| Schedule of Disaggregation of Revenue by Channel |
|
|
|
Year ended
|
| |
|
December 31, 2020
|
|
December 31, 2019
|
|
Mass retail
|
|
$
|
6,879 |
|
$
|
3,318 |
|
Specialty, health and other retail
|
|
|
689 |
|
|
1,235 |
|
Distributors
|
|
|
4,036 |
|
|
2,397 |
|
E-commerce
|
|
|
513 |
|
|
885 |
| |
|
$
|
12,117 |
|
$
|
7,834 |
|